FDA Considers Approval for Moderna's mRNA Flu Vaccine

Why it matters locally: The potential approval of Moderna's mRNA flu vaccine could influence healthcare accessibility and public health strategies across Arkansas, including how local health departments like those overseen by the Arkansas Department of Health manage flu season preparations.

---

The Food and Drug Administration (FDA) is preparing to issue a ruling on Moderna's messenger RNA (mRNA) flu vaccine. This vaccine, if approved, would become the first mRNA-based influenza shot available commercially. Observers expect the FDA's decision to affect the biotechnology industry broadly.